Safety and Efficacy of APG-157 in Head and Neck Cancer
Safety and Efficacy of APG-157 in Head and Neck Cancer
Active, not recruiting · NCT05312710 · Registry updated 2026-01-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of APG-157 in Head and Neck Cancer | Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, head and neck cancer, head and neck squamous cell carcinoma, mouth disorder, neoplasm, oral cavity squamous cell carcinoma, otorhinolaryngologic disease, squamous cell carcinoma | Active, not recruiting | Phase 2 | 2026-01-16 | NCT05312710 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Aveta Biomics, Inc. | 4 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Miami Sylvester Comprehensive Cancer Center | Miami | United States | 18 |
| VAGLAHS, West Los Angeles | Los Angeles | United States | 1 |